Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581M Hold
1,120,000
6.45% 8
2026
Q1
$555M Hold
1,120,000
6.86% 5
2025
Q4
$478M Hold
1,120,000
5.13% 9
2025
Q3
$532M Hold
1,120,000
5.79% 6
2025
Q2
$525M Hold
1,120,000
6.06% 6
2025
Q1
$522M Hold
1,120,000
6.52% 7
2024
Q4
$469M Hold
1,120,000
5.66% 7
2024
Q3
$534M Hold
1,120,000
6.5% 5
2024
Q2
$491M Hold
1,120,000
6.29% 5
2024
Q1
$520M Hold
1,120,000
6.25% 4
2023
Q4
$460M Hold
1,120,000
5.7% 5
2023
Q3
$417M Hold
1,120,000
5.54% 5
2023
Q2
$427M Hold
1,120,000
5.62% 6
2023
Q1
$398M Hold
1,120,000
5.55% 5
2022
Q4
$365M Hold
1,120,000
5.4% 7
2022
Q3
$302M Buy
1,120,000
+110,000
+11% +$31.6M 4.73% 8
2022
Q2
$290M Hold
1,010,000
3.79% 15
2022
Q1
$323M Hold
1,010,000
3.37% 18
2021
Q4
$350M Hold
1,010,000
3.32% 20
2021
Q3
$296M Hold
1,010,000
2.93% 20
2021
Q2
$292M Buy
1,010,000
+560,000
+124% +$163M 2.78% 20
2021
Q1
$126M Buy
+450,000
New +$117M 1.32% 23

Other funds holding LIN

Wellcome Trust's LIN Position: Q2 2026 in Review

Wellcome Trust held its Linde (LIN) position steady in Q2 2026 at 1,120,000 shares worth $581M. The position accounts for 6.45% of the portfolio, ranked #8.

Wellcome Trust first reported a position in LIN in Q1 2021 and has held it in 22 quarters since. 916 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Wellcome Trust held 1,120,000 shares of Linde worth $581M as of Q2 2026.
  • Wellcome Trust left its Linde share count unchanged in Q2 2026.
  • Linde made up 6.45% of Wellcome Trust's portfolio in Q2 2026, its #8 holding.
  • Wellcome Trust first reported a position in Linde in Q1 2021 and has held it in 22 quarters since.
  • 916 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.